Some links on this page are affiliate links: if you buy through them we may earn a commission, at no extra cost to you.
Health-tech and startup pitches can sound convincing while hiding unsupported medical claims, overstated regulatory status, invented traction, or misuse of investor money. The fastest way to spot warning signs is to separate every promise into a testable claim, demand primary records, verify those records independently, and treat each anomaly as a reason to investigate—not automatic proof of fraud.
This guide is U.S.-focused because its regulatory examples come from the FDA, FTC and SEC. It is a due-diligence framework, not legal or investment advice. A founder may be mistaken, overly optimistic or noncompliant without intending fraud; intent and liability require evidence and, ultimately, a proper legal process.
What is a warning sign of fraud in a health-tech pitch?
A warning sign is a mismatch between what a company says and what its underlying records, scientific evidence, regulatory permissions or financial statements support. A single inconsistency can have an innocent explanation. Several independent inconsistencies—especially when a founder refuses reasonable verification—deserve a pause before you invest, buy, prescribe or recommend a product.
Recommended Free Tools
Start by writing the exact sentence you heard. “Our test detects cancer early,” “FDA approved,” “insurers reimburse 80% of claims,” and “we have $10 million in recurring revenue” are four different assertions. They require different evidence. Marketing language often blends clinical performance, legal authorization, payment history and forecasts into one impression of certainty.
Popular on Amazon
- 【90 Degree Full Function USB C Adapter】Supports the latest USB4 standard for up to 40Gbps of bandwidth, 8K video support, and up to 240W Fast charging; Support USB PD 3.1 Extended Power Range (EPR) including 140W, 180W and 240W. Your productivity is easily doubled. *Warm Tip: For the best fit, please make sure the USB-C port is fully exposed; thick or bulky cases may affect compatibility.
- 【Reliable Quality】Made from high-quality, scratch-resistant aluminum alloy, delicate metal frame. get excellent wear resistance and heat dissipation. Non-Slip Design for easier insertion and removal.
- 【Small and portable】Ultra thin size, ultra compact design, a petite physique that matches the minimalist design of your modern laptops. Coming with a slim figure that won't block the port next to the one it's plugged into.
- 【Compatibility】Widely work with most usb c, thunderbolt 4/3 devices. Compatibilit for ROG Ally, Steam Deck, Switch, MacBook Pro, Quest 3 VR headset, Surface Book 2, iPhone 18/17/16/15, Samsung Galaxy S23/S22/S21, Note 20/10, Google Pixel, ChromeBook, etc.
- 【Excellence Customer Support】If you experience any issues or cable failure, simply reach out to our dedicated customer service team. We provide a prompt response within 18 hours, providing you with the necessary technical support to resolve any concerns.
The FDA’s health-fraud guidance defines health fraud as deceptive promotion, advertising, distribution or sale of a product represented as preventing, diagnosing, treating, curing or lessening an illness—or providing another health benefit—without scientific proof that it is safe and effective for that purpose. That definition explains why a dramatic outcome claim is not evidence in itself.
Which pitch behaviors should make you pause?
The following signals are practical prompts for verification. None, by itself, proves criminal conduct. They become more concerning when the company cannot provide records, changes its story, or asks you to rely on secrecy and urgency instead of evidence.
| Warning sign | Why it matters | What to request or check |
|---|---|---|
| Miracle-level benefit with no precise endpoint | “Cures,” “reverses” or “finds every cancer” claims may exceed what a study measured. | Protocol, population, comparator, endpoint definitions, confidence intervals and limitations. |
| Testimonials replacing clinical data | Individual stories cannot establish safety, sensitivity, specificity or comparative benefit. | Peer-reviewed or otherwise fully documented studies and the people who conducted them. |
| Regulatory name-dropping | “FDA registered,” “FDA listed” or a database entry does not necessarily mean a product is cleared or approved for the claimed use. | Exact product, model, intended use, decision number, labeling and scope of authorization. |
| One approval presented as approval for everything | A clearance or authorization is tied to a particular device, indication and labeling. | Compare the pitch’s wording with the agency decision and current instructions for use. |
| Reimbursement figures without payment records | Submitted claims, allowed amounts and cash actually collected are different metrics. | De-identified remittance advice, payer contracts, denial rates, collection timing and repeatable unit economics. |
| Revenue described only as a forecast | Pipeline, letters of intent and booked revenue are not interchangeable. | Bank statements, invoices, contracts, renewal data and a reconciliation to financial statements. |
| Vague use-of-funds language | “Advance the platform” cannot be tied to a measurable milestone or budget. | Line-item budget, responsible person, timeline, board reporting and variance explanations. |
| Pressure to keep treatment details secret | Secrecy can prevent a qualified clinician or investor from checking safety and evidence. | Ask for an independent medical review and written rationale for any confidentiality limit. |
| Refusal to allow a second opinion | Legitimate developers should expect scrutiny of high-stakes claims. | Have a specialist, regulatory lawyer or qualified technical reviewer inspect the records. |
| Physical product does not match its description | A nonfunctional or substituted component can make performance claims meaningless. | Inspect bills of materials, photographs, manufacturing records, validation tests and chain of custody. |
The FDA’s consumer advice similarly recommends skepticism toward claims that sound too good to be true and consultation with a medical specialist when a treatment is unproven or little-known. FDA health-fraud coordinator Reynaldo Rodriguez summarized the approach as: “Look into it–before you put it in your body or on your skin.” That advice applies to verifying the evidence behind a startup’s product, not to assuming every young company is fraudulent.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →How can you verify a startup’s clinical claims?
Ask for the underlying study rather than a slide that summarizes it. Then check whether the study actually answers the question the pitch implies.
- Define the claimed use. Record the disease, patient population, setting, specimen, treatment or diagnostic workflow, and the outcome being promised. “Improves outcomes” is incomplete unless the company specifies which outcome, over what period and compared with what.
- Identify who conducted and funded the work. Obtain authors, institutions, sponsors, conflicts of interest, ethics approval information and the date of data collection. A company-funded study can still be useful, but its sponsorship and analytic controls should be visible.
- Read the protocol and methods. Ask how participants were selected, whether there was a control or comparator, how missing data were handled, and whether the analysis was prespecified. For a diagnostic, request sensitivity, specificity, positive and negative predictive values, confidence intervals and the prevalence assumptions used to calculate them.
- Check that the sample fits the pitch. A small, selected research cohort may not represent primary-care patients, people with coexisting conditions or the population named in the sales deck. Confirm inclusion and exclusion criteria, geography and recruitment dates.
- Separate surrogate outcomes from patient outcomes. A change in a biomarker, image or laboratory signal does not automatically show longer survival, fewer hospitalizations, better function or improved quality of life.
- Look for replication and contrary findings. Ask whether an independent group reproduced the result and whether the company discloses null, adverse or discontinued studies. A polished abstract is not a substitute for the full report.
- Compare wording with evidence. If a study says “associated with” and the pitch says “proves,” or if a pilot is presented as a definitive trial, record the mismatch and ask the founders to correct it in writing.
The Federal Trade Commission’s HHealth closing letter describes the agency’s stated expectation that health-benefit and safety claims be supported by competent and reliable scientific evidence, conducted and evaluated objectively by qualified people and generally accepted in the profession to produce accurate and reliable results. The letter concerns a specific matter; use it as a substantiation standard to discuss with counsel, not as a complete statement of every applicable law.
How do you check whether a medical device is FDA approved?
Do not treat “FDA registered,” “FDA listed,” “FDA compliant” or a screenshot of a database as synonyms for approval or clearance. Ask exactly what product and intended use the agency action covers.
Also popular on Amazon
- 5-in-1 Connectivity: Equipped with a 4K HDMI port, a 5 Gbps USB-C data port, two 5 Gbps USB-A ports, and a USB C 100W PD-IN port. Note: The USB C 100W PD-IN port supports only charging and does not support data transfer devices such as headphones or speakers.
- Powerful Pass-Through Charging: Supports up to 85W pass-through charging so you can power up your laptop while you use the hub. Note: Pass-through charging requires a charger (not included). Note: To achieve full power for iPad, we recommend using a 45W wall charger.
- Transfer Files in Seconds: Move files to and from your laptop at speeds of up to 5 Gbps via the USB-C and USB-A data ports. Note: The USB C 5Gbps Data port does not support video output.
- HD Display: Connect to the HDMI port to stream or mirror content to an external monitor in resolutions of up to 4K@30Hz. Note: The USB-C ports do not support video output.
- What You Get: Anker 332 USB-C Hub (5-in-1), welcome guide, our worry-free 18-month warranty, and friendly customer service.
- Get the agency pathway and identifier. Request the 510(k) number, De Novo order, premarket approval number, humanitarian device exemption, emergency-use authorization or other pathway the company says applies. If the founder cannot name the pathway, ask why.
- Match the product. Confirm manufacturer, model, software version, accessories, indications, patient population and professional setting. An authorization for one model or indication may not cover a modified device or a new clinical claim.
- Read the labeling. Compare promotional language with the authorized indications, contraindications, warnings and instructions for use. Claims outside that scope need their own substantiation and may raise compliance issues.
- Check public FDA material. Search the relevant device databases and the FDA’s health-fraud warning-letter listings. A warning letter addresses violations of regulatory significance and seeks voluntary compliance; it is an important signal, not a final court judgment.
- Confirm current status. Ask whether the product is under a recall, import alert, quality-system action or corrective plan. FDA notes that later interactions can change the status of matters described in a warning letter, so read the specific letter and any subsequent agency communication.
For a treatment or diagnostic offered outside the United States, identify the regulator and legal pathway in that country. U.S. FDA status does not automatically establish authorization, reimbursement or lawful marketing elsewhere.
What should you ask founders about reimbursement and revenue?
Require a bridge from the headline number to cash that can be independently reconciled. “We have $5 million in reimbursement” could mean submitted charges, contractual allowed amounts, paid claims, or a forecast; those figures have very different risk profiles.
- Request a claims roll-up. Ask for claim count, payer, service date, code, billed amount, allowed amount, payment date, denial or appeal status and net collection. Use de-identified records when patient privacy requires it.
- Distinguish one-off from repeatable economics. A pilot, grant, single unusual payer decision or founder-affiliated clinic should not be presented as a stable market rate. Ask how many independent sites generated paid claims and over what period.
- Check coding and coverage. Identify the exact CPT, HCPCS, ICD or local equivalent codes, coverage policy and medical-necessity requirements. A code’s existence does not guarantee payment.
- Reconcile revenue. Compare the claims schedule with bank deposits, invoices, general-ledger entries, audited or reviewed statements and tax filings where available. Investigate timing differences and related-party transactions.
- Model downside. Calculate economics using actual collection rates, payment delays, refunds, prior-authorization costs, clinician time and customer-acquisition expense—not the most favorable contract rate.
The SEC’s 2021 uBiome litigation release described allegations that co-founders represented rapid growth and a strong history of insurance reimbursement for clinical tests while defrauding investors of $60 million. Those are SEC charges and allegations described in the release, not a general statistic about startups. The case illustrates why a pitch’s own reimbursement summary should be tested against source records.
How do you verify a startup’s use of funds?
Turn every proposed use of proceeds into a milestone, a budget and a reporting trail. “Clinical development” should resolve into named studies, vendors, regulatory submissions, staffing, dates and amounts.
- Request the financing documents. Read the offering memorandum, subscription agreement, capitalization table, board approvals and any restrictions on proceeds. Confirm whether money is equity, debt, a grant or a convertible instrument.
- Build a milestone budget. Map each dollar to payroll, contract research, manufacturing, quality systems, clinical sites, regulatory fees and overhead. Note the trigger for releasing additional capital.
- Set reporting dates. Require periodic bank reconciliations, budget-to-actual reports, trial-enrollment updates, regulatory correspondence and explanations for material variances.
- Check related parties. Look for payments to founders, family members, entities they control, unusual loans, luxury purchases or consulting arrangements that were not disclosed and approved.
- Follow the money independently. Where appropriate, obtain confirmation from the company’s accountant, escrow agent, contract research organization or manufacturing partner. A vendor invoice alone does not prove that work was performed.
A complaint filed by the SEC on January 15, 2026, naming SVN Med, NVS Med, Onco Filtration and Cancer Check Labs, alleges that more than $26 million was raised from over 180 investors and that at least $10.6 million was diverted for personal use despite representations that funds would support technology development, research, clinical trials and regulatory work. These figures are allegations in a complaint, not adjudicated findings or a prevalence estimate. The case shows why use-of-funds promises must be tied to bank-level evidence and completed milestones.
Do these 3 things before closing this tab:
1Clear out junk files and repair common Windows errors2Fix the driver behind crashes, sound loss and screen glitches3Repair Windows errors before they cause bigger problemsWhy does the physical device matter?
A device can be misrepresented even when a company has impressive drawings, patents or a regulatory file. Confirm that the component described in the pitch exists, functions as claimed and is the component used in validation and patient-facing operation.
Also popular on Amazon
- Sleek 7-in-1 USB-C Hub: Features an HDMI port, two USB-A 3.0 ports, and a USB-C data port, each providing 5Gbps transfer speeds. It also includes a USB-C PD input port for charging up to 100W and dual SD and TF card slots, all in a compact design.
- Flawless 4K@60Hz Video with HDMI: Delivers exceptional clarity and smoothness with its 4K@60Hz HDMI port, making it ideal for high-definition presentations and entertainment. (Note: Only the HDMI port supports video projection; the USB-C port is for data transfer only.)
- Double Up on Efficiency: The two USB-A 3.0 ports and a USB-C port support a fast 5Gbps data rate, significantly boosting your transfer speeds and improving productivity.
- Fast and Reliable 85W Charging: Offers high-capacity, speedy charging for laptops up to 85W, so you spend less time tethered to an outlet and more time being productive.
- What You Get: Anker USB-C Hub (7-in-1), welcome guide, 18-month warranty, and our friendly customer service.
Ask for a controlled bill of materials, serial-number records, engineering change orders, verification and validation reports, quality-system certificates, supplier records and photographs or demonstrations that an independent expert can inspect. For software-enabled products, verify the released version, cybersecurity documentation, data flows and whether the tested algorithm is the one being sold.
In a December 19, 2023 release, the SEC said it charged former Stimwave CEO Laura Tyler Perryman with defrauding investors of approximately $41 million. The SEC described allegations that a peripheral nerve stimulation system included a fake, non-functional component and that investors received false or misleading statements about a key product. Phrase this as an agency charge and alleged conduct; the release’s procedural posture does not permit treating every allegation as an adjudicated fact.
What do enforcement examples teach—and what do they not prove?
Enforcement records are useful case studies because they show the kinds of documents and representations investigators scrutinize. They do not establish that every company with a similar business model is fraudulent, nor do the dollar amounts provide a reliable rate of fraud in health-tech.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
uBiome: verify growth and reimbursement narratives
The SEC’s March 19, 2021 litigation release says it charged co-founders Jessica Richman and Zachary Apte with defrauding investors of $60 million. According to the release, the allegations involved representations about rapid growth and a strong history of insurance reimbursement for clinical tests. The diligence lesson is to reconcile customer counts, test volume, paid claims and cash receipts rather than accepting a chart copied from an investor deck.
Stimwave: verify that the product is what the pitch says it is
The SEC’s 2023 release concerning Stimwave describes charges against a former CEO over approximately $41 million and allegations involving a fake, non-functional component. The practical lesson is physical and documentary: inspect the actual configuration, validation evidence and manufacturing records, and compare them with what investors and customers were told.
2026 cancer-related device complaint: verify the destination of capital
The SEC complaint concerning SVN Med, NVS Med, Onco Filtration and Cancer Check Labs alleges more than $26 million raised from over 180 investors and at least $10.6 million allegedly misappropriated for personal use. Because a complaint is an allegation, use it to understand a diligence question—whether promised research and regulatory spending can be traced—not to declare guilt before the case is resolved.
Also popular on Amazon
- Portable and powerful USB-C HUB: BENFEI USB Type-C HUB, with super-soft and knot-free silicone woven design cable, meets most mobile office needs. Compact, lightweight, stylish, and powerful portable USB C Hub equipped with 1 x HDMI port, 1 x 100W charging, and 3 x USB ports. 18-month warranty, 24-hour response, to ensure you feel at ease when using our product.
- Design centered on comfort and reliability: Thanks to BENFEI's end-to-end in-house cable production capability, in-house PCBA and assembly capability, using the industry's most advanced silicone woven design and process, 20cm cable in length, no knots, super-soft, the HUB is easy to use in all scenarios: laptop, tablet, stand etc. Super-soft, 25000+ life cycles, to meet your daily carrying and office needs.
- 100W Charging: Support up to 90W USB C pass-through charging via Type-C port to keep your laptop powered. 10W is reserved for other interface operations. No data and video function on the Type-C port.
- 4K HDMI Display: The HDMI port supports media display at resolutions up to 4K 30Hz, keeping every incredible moment detailed and ultra vivid. Please note that the C port of the Host device needs to support video output.
- Transfer Files in Seconds: Transfer files and from your laptop at speeds up to 10 Gbps with USB A 3.2 port. Extra 2 USB A 2.0 ports are perfectly for your keyboards and mouse.
How do you distinguish a warning sign from proof of fraud?
Use a three-level classification. Unverified means you have a claim but no satisfactory primary evidence. Contradicted means reliable records conflict with the claim. Fraud evidence requires proof of the relevant elements, including intent where the law requires it, and should be assessed by qualified investigators or courts.
Document what you asked, what was supplied, when it was supplied and how you verified it. Give the company a fair opportunity to explain a discrepancy, especially when records are old, confidential or affected by a legitimate accounting or regulatory transition. A refusal to answer, fabricated document, altered timestamp or repeated story change raises the risk level, but still warrants careful preservation of evidence and professional advice rather than public accusation.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What is a practical due-diligence workflow?
Use this sequence before committing money, referring patients or relying on a product in care:
- Freeze the claim. Save the deck, website, email and demo recording. Quote the exact language and date.
- Classify it. Mark each statement as clinical, safety, regulatory, reimbursement, commercial, ownership or use-of-funds.
- Set an evidence threshold. Decide in advance what primary document would confirm or disprove the claim.
- Request records in writing. Ask for full studies, protocols, agency decisions, labels, claims data, contracts, bank reconciliations and budgets—not selected screenshots.
- Verify outside the company. Contact the regulator through its public records, confirm publications with the journal or registry, and obtain independent technical, medical, accounting or legal review.
- Compare versions. Check whether the pitch, data room, website, regulatory filing and customer contract use the same product name, indication, revenue definition and dates.
- Make a go/no-go decision. Proceed only when material claims are supported and unresolved risks are explicitly priced, mitigated or accepted by the appropriate decision-maker.
- Keep monitoring. A clean initial review does not replace ongoing checks of adverse events, recalls, reimbursement changes, trial results, cash use and regulatory correspondence.
For a medical treatment, do not delay necessary care while investigating a startup. A clinician should make patient-care decisions, and an attorney or qualified financial professional should advise on legal and investment exposure.
How should you respond to pressure tactics?
Slow the process when a founder says the round closes today, promises guaranteed returns, discourages written questions or insists that details are “too sensitive” for an independent review. Confidentiality agreements can protect legitimate trade secrets, but they should not prevent a qualified reviewer from assessing safety, authorization, finances or conflicts.
Free tools Windows power users keep installed
One-click scans. No signup required.
Use a written request with a deadline, list the missing evidence and state that the decision is paused until the material issues are resolved. Do not send additional funds to “unlock” records, pay an urgent regulatory fee or recover an earlier investment. Preserve messages and documents, and seek advice on reporting options if you suspect misconduct.
Also popular on Amazon
- 【Read before You Buy】 Note: This adapter is USB 2.0 version and cannot transmit HDM, VGA, or other video signals. Nevertheless, they are fully capable of charging devices,duplicating files, and can be seamlessly integrated with USB-C earphones, wireless network adapters, and SD card adapters.
- 【Easy to Use and Safe】Thanks to modern manufacturing techniques, we've made these adapters sufficiently compact so that they can remain inserted in your device without noticeable protrusion or inconvenience. This means you don't have to constantly plug and unplug them, reducing the likelihood of wear and misalignment, and making them more convenient to carry around.
- 【Reliable Quality】Engineered for enhanced durability, durable aluminum alloy shell material,get excellent wear resistance and heat dissipation,the male USB C and female USB connectors & the male USB and female USB C connectors are designed to be plugged and unplugged up to 20000 times. Provides data transfer, device charging, memory space expansion, and additional computer peripherals.
- 【Think more for you】Do you need to connect a USB-C-enabled device to an odd device that only has USB-A ports? Then these USB-A male to USB-C female adapters are made for you.Simply insert the adapter into the USB-A port on the device, and you can instantly connect your USB-C device to the device that originally didn't have the correct connection port.
- 【Trusted xiwxi Quality and Service】As a responsible brand seller, you will receive xiwxi's 12-month Quality assurance and lifetime friendly customer service, you're not just buying a product,you're investing in peace of mind with all-round quality and exceptional customer service.
What are the limits of this framework?
FDA guidance and warning letters address U.S. food, drug and medical-device oversight; FTC substantiation expectations arise from U.S. consumer-protection work; SEC releases and complaints concern U.S. securities enforcement. Other countries use different regulators, authorization pathways, privacy rules, accounting standards and investor-protection laws. A database search or warning letter is not a universal verdict, and the absence of a public enforcement record is not proof that a pitch is sound.
The research behind this guide provides case-specific enforcement figures, not a dependable population estimate of how often health-tech pitch fraud occurs. Treat the examples as illustrations of verification failures, not as a scoring system or a prediction of any company’s intent.
What should you do before saying yes?
Write down the claim, obtain the primary evidence, verify it independently and insist on a second opinion for high-stakes medical or financial decisions. If the company cannot show what was measured, what was authorized, who paid, where the money went and how the product matches its description, the prudent response is to pause—not to fill the gaps with optimism.
Frequently Asked Questions
Can a startup be fraudulent if its product is not FDA approved?
No. Lack of FDA approval may mean the product is investigational, exempt, outside FDA jurisdiction or being marketed unlawfully, depending on the facts. Verify the device’s exact pathway and intended use; treat unsupported claims or evasive answers as diligence risks rather than proof of intent.
What documents should I request before investing in a health-tech company?
Request the full clinical protocols and reports, regulatory decisions and labeling, claims and payment summaries, customer contracts, financial statements, capitalization table, use-of-funds budget and bank-level reporting. Ask for records in a form an independent medical, regulatory or accounting reviewer can evaluate.
Are testimonials ever useful evidence for a medical startup?
They can reveal how a product is experienced or help identify questions, but they cannot establish safety, effectiveness or generalizability. Compare every testimonial-based promise with controlled evidence in the relevant patient population.
How should I handle a founder who refuses to share data because of trade secrets?
Accept reasonable confidentiality protections, such as a nondisclosure agreement or a qualified third-party review, but do not waive verification of material safety, regulatory or financial claims. A blanket refusal to provide any checkable evidence is a reason to pause the transaction.
Say something about this film